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Case ReportsWhen recognized postoperatively, the patient’s past
history of IE, 2 cardiac operations, and poor clinical
condition suggested that another reoperation would be
high risk, which led to the decision to close the fistula
with an Amplatzer device. Failure to close the shunt
percutaneously worsened his heart failure and resulted in
ascites, intravascular hemolysis, jaundice, and renal failure.
Successful cases of transcatheter closure of acquired
LV-RA fistulas have been reported,2 and device closure
was a reasonable option in this patient, although long-
term results are unknown. In our case, however, when the
device closure had failed and the patient’s heart failure
worsened, there was little excuse for not referring
this young man early to a center with more experience
performing complex reoperations.From the Thoracic Surgery Department, MDAnderson Cancer Center, Houston, Tex.
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1495-8.Sternal metastasis of renal cell carcinoma: The role
of metastasectomyNaruhiko Ikoma, MD, and Ara Vaporciyan, MD, Houston, TexSternal metastasis of renal cell carcinoma (RCC) has rarely
been reported in the literature.1 This case series describes
the presentation and management of 3 patients with isolated
sternal metastasis of RCC treated with sternectomy with
curative intent.
CLINICAL SUMMARIES
Patient 1
A 40-year-old man was seen in April 2004 with an
enlarging sternal mass. Computed tomography revealed a
lytic lesion involving the entire manubrium and a mass in
the left kidney. Biopsy of the renal mass revealed an unclas-
sified RCC. Despite chemotherapy, the disease progressed.
In October 2004, the patient underwent en bloc chest wall
resection of a portion of the sternum, both clavicular heads,
and the medial first and second ribs. Reconstruction was
performed with Prolene mesh (Ethicon, Inc, Somerville,
NJ) and a left pectoralis major muscle flap. The pathology
report indicated an 8.5 3 6.5 3 6.0-cm metastatic RCC.In December 2004, left radical nephrectomy was per-
formed, and the pathology report revealed a 6.5-cm unclas-
sified RCC (Fuhrman nuclear grade 3) with invasion into
the perinephric adipose tissue and vascular lymphatic
spaces. In July 2007, brain and rib metastases were discov-
ered. The patient underwent stereotactic radiosurgery and
several craniotomies, followed by chemotherapy; however,
the disease progressed, and the patient died in April 2011.
Patient 2
A 60-year-old man was seen with an enlarging sternal
mass in February 2013. Biopsy revealed metastatic RCC,
and computed tomography revealed a right kidney tumor.
A right radical nephrectomy was performed in May 2013.
The histopathologic diagnosis was clear cell RCC
(Fuhrman nuclear grade 3). Because of the large size of
the sternal metastasis, the patient underwent adjuvant
chemotherapy, to which there was partial response. In
October 2013, the patient underwent total sternectomy
and reconstruction with GORE-TEX mesh (W. L. Gore &
Associates, Flagstaff, Ariz), titanium sternal bars, bilateral
pectoralis major flaps, and pedicled right rectus abdominis
muscle flap. The pathology report of the sternal lesion re-
vealed an 8.5 3 7.3-cm metastatic RCC.
Patient 3
A 47-year-old man was seen with a painful mass at the
medial border of his left clavicle. Biopsy in Novembergery c November 2014
TABLE 1. Characteristics of patients with renal cell carcinoma with
reported isolated sternal metastasis
Total patients 11
Age (y) 58.1  12.6
Sex (male) 82% (9/11)
Symptoms of sternal mass 100% (11/11)
Biopsy of sternal mass 70% (8/11)
Synchronous metastasis 91% (10/11)
Primary tumor size (cm) 4.6  1.7
Sternal tumor size (cm) 6.7  1.9
Operation
Nephrectomy 100% (11/11)
Partial sternectomy 73% (8/11)
Total sternectomy 9% (1/11)
Palliative radiation 18% (2/11)
Manubrium resected 75% (6/8)
Involved rib levels 2.2  0.4
Reconstruction
Mesh 67% (6/9)
Bar 11% (1/9)
Pectoralis muscle flap 33% (3/9)
Rectus abdominis muscle flap 22% (2/9)
Operative complication
Respiratory 0% (0/9)
Wound infection 11% (1/9)
Osteochondritis 11% (1/9)
Perioperative systemic therapy 22% (2/9)
Perioperative radiation therapy 22% (2/9)
Case Reports2011 revealed metastatic RCC. Computed tomography
showed a left kidney mass. Left nephrectomy was per-
formed, and clear cell RCC (diameter, 5.8 cm; Fuhrman nu-
clear grade 3) with invasion into renal sinus vessels was
revealed. Two weeks later, the patient underwent resection
of the left clavicle and part of the manubrium; metastatic
RCC (diameter, 4.5 cm) was revealed. In February 2012,
short-interval local recurrence in the manubrium was
discovered, and repeat partial manubriectomy and resection
of left infraclavicular soft tissue mass were performed. Af-
ter another recurrence in the manubrium in November 2013,
the patient was referred to the MDAnderson Cancer Center,
where he underwent complete manubriectomy without
reconstruction. Pathology revealed metastatic RCC (diam-
eter, 3.8 cm). The patient’s recovery was complicated by
a surgical site infection and asymptomatic bilateral pulmo-
nary embolisms. He underwent percutaneous drainage with
resolution and also underwent therapeutic anticoagulation.DISCUSSION
Sternal metastasis has frequently been reported in pa-
tients with breast cancer, and metastasectomy has been sug-The Journal of Thoracic and Cargested to improve survival. Although the role of surgical
resection in the treatment of isolated sternal metastasis in
breast cancer is recognized, its application in other malig-
nancies has not been appreciated.
Accumulating evidence indicates a potential survival
benefit associated with surgical resection of the primary
tumor in patients with metastatic RCC. In a randomized,
controlled trial of 246 patients with metastatic RCC, me-
dian survival was significantly longer among the patients
who underwent nephrectomy before receiving interferon
alfa therapy than among those who received interferon
alfa therapy alone.2 Although there clearly could be selec-
tion bias in choosing who was enrolled, it was concluded
that there was benefit of cytoreduction surgery for RCC
in the population studied. In addition, although no pro-
spective studies have been reported, a retrospective anal-
ysis of 278 patients with metastatic RCC found the
highest survival among those patients who underwent
curative metastasectomy (5-year survival of 44%).3 A
similar result was reported for osseous metastasis of
RCC, with a 5-year survival of 55% in the surgical resec-
tion group.4
Our literature review revealed 8 additional cases of iso-
lated sternal metastasis of RCC (Table 1). Survival cannot
be determined because of the short follow-up in most re-
ports; however, our case reviews have indicated at least 3
patients with survivals longer than 5 years. At the MD An-
derson Cancer Center, once the primary lesion has been
controlled, our recommendation in the Thoracic Surgery
Department ideally is to perform sternal metastasectomy
if the sternal metastasis is isolated and completely resect-
able. The addition of chemotherapy before metastasectomy
would be dependent on the resectability. The decision to
provide systemic therapy is usually made at a multidisci-
plinary conference on a case-by-case basis.
Althoughprevious reports have demonstrated the resection
of sternal metastases, this report demonstrates that despite
new biologic therapy (eg, sorafenib), there is still a role for
resection in the treatment of carefully selected patients.
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